gip and glp 1 drugs Frontiers GLP-1 receptor agonists | How

While Mounjaro has shown promising results, it is still a newer product with relatively limited market penetration compared to the more established options from Novo

Girish PJ, Abdelmalak BB, Weigal WA, et al

Nausea, vomiting, diarrhea, constipation, and abdominal pain were mainly transient and mild to moderate in severity

1 We describe two cases of patients taking GLP-1 receptor agonists that were found to have high volumes of complex gastric contents despite appropriate fasting per American Society of Anesthesiologists (ASA) practice guidelines for preoperative fasting

doi: 10.1016/j.cmet.2023.11.009 269 McLeanBAWongCKKaurKDSeeleyRJDruckerDJ

Prior authorizations, insurance rejections, and coverage clarifications are more frequent for obesity indications